LUNG CANCER (NON-SMALL CELL)

This study is testing whether adding a new drug called capivasertib to a standard lung cancer drug (osimertinib) can help control advanced non-small cell lung cancer that has specific genetic changes and has started growing again after initial treatment. It will involve about 53 …

This study is testing a new drug called ivonescimab for people with advanced non-small cell lung cancer that has specific genetic changes and has stopped responding to standard treatments. It will test the drug by itself in one group of patients, and combined with standard chemot…

This early-stage study is testing a new cell-based treatment called SL-28 in adults with advanced solid tumors that have not responded to standard therapies. The main goals are to find the safest and most effective dose and to check for side effects. Participants will receive the…

This study aims to find the best breathing machine settings during lung cancer surgery to reduce lung complications after the operation. Researchers will test different breathing volumes in 650 patients undergoing minimally invasive lung surgery. The goal is to determine which ap…

This study aims to understand if a person's fitness level and a short, intense exercise program before lung cancer surgery can change the environment around the tumor and lead to better recovery. Researchers will measure fitness using wearable devices and have some participants c…

This study aims to understand why some lung cancer patients respond well to immunotherapy drugs while others do not. Researchers will collect and analyze sputum (mucus from the lungs) and blood samples from 50 patients before and during their standard immunotherapy treatment. The…

This study aims to see if simple blood tests can detect cancer markers as effectively as invasive tissue biopsies. Researchers will enroll 620 patients with various cancers, focusing on lung cancer, to compare blood test results with traditional biopsy methods. The goal is to dev…